Who owns KAIROS PHARMA LTD?
- Ticker: KAPA
- CUSIP Number: 48301n104
Tip: Access positions for across all investors
Analyze quarterly positions in Kairos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kairos Pharma stock
Who bought or sold KAIROS PHARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 132k | $154k | 100% | Sep 2025 |
|
| Geode Capital Management | 66k | $77k | 202% | Sep 2025 |
|
| Two Sigma Investments | 46k | $54k | 100% | Sep 2025 |
|
| Aptus Capital Advisors | 44k | $52k | 0% | Sep 2025 |
|
| SevenBridge Financial | 44k | $38k | 0% | Sep 2025 |
|
| Two Sigma Securities | 25k | $29k | 84% | Sep 2025 |
|
| State Street Corporation | 24k | $28k | 100% | Sep 2025 |
|
| XTX Topco | 12k | $15k | -80% | Sep 2025 |
|
| UBS Group | 6.0k | $7.0k | -37% | Sep 2025 |
|
| Tower Research Capital | 6.0k | $7.0k | 57% | Sep 2025 |
|
| Royal Bank of Canada | 1.0k | $1.0k | 100% | Sep 2025 |
|
Who sold out of Kairos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Jun 2025 | 13k | $9.0k |